Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against schistosoma

Bioorg Med Chem Lett. 2005 May 2;15(9):2415-9. doi: 10.1016/j.bmcl.2005.01.040.

Abstract

Based on the two antigenic peptides, 26-43 (P26) and 116-131 (P116), derived from 28 kDa glutathione S-transferase of Schistosoma mansoni (Sm28GST), two multiple antigenic peptides (MAPs), (P26)4-MAP and (P116)4-MAP with the same oligomeric lysine core, were synthesized by stepwise solid-phase peptide synthesis method. The antigenicities and protective effects of these two MAPs were examined on experimental animals. As shown in the dot-ELISA result, the synthetic MAPs could be recognized and bound by immunoglobins in both patient's and infected-rabbit's sera. After Kunming mice were immunized with (P26)4-MAP, the worm burden reduction rate and the liver egg reduction rate were 59.9% and 61.1%. In (P26)4-MAP or (P116)4-MAP immunized BALB/c mice, the worm burden reduction rates were 37.5% and 62.5%, respectively, and the liver egg reduction rates were 35.1% and 54.0%, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Helminth / pharmacology*
  • Glutathione Transferase / chemistry
  • Mice
  • Mice, Inbred BALB C
  • Peptides / chemical synthesis*
  • Peptides / pharmacology*
  • Schistosoma mansoni / enzymology
  • Schistosoma mansoni / microbiology
  • Schistosomiasis mansoni / immunology*
  • Vaccines*

Substances

  • Antigens, Helminth
  • Peptides
  • Vaccines
  • Glutathione Transferase